Kawasaki S, Ohtsuka H, Sato Y, Douchi D, et al. Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signaling. Pancreatology 2021 Mar 3. pii: S1424-3903(21)00068.
PMID: 33707114